𝐍𝐨𝐫𝐭𝐡 𝐀𝐦𝐞𝐫𝐢𝐜𝐚 𝐂𝐞𝐥𝐥 & 𝐆𝐞𝐧𝐞 𝐓𝐡𝐞𝐫𝐚𝐩𝐲 𝐌𝐚𝐧𝐮𝐟𝐚𝐜𝐭𝐮𝐫𝐢𝐧𝐠 𝐒𝐞𝐫𝐯𝐢𝐜𝐞𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 𝐒𝐢𝐳𝐞, 𝐒𝐡𝐚𝐫𝐞 & 𝐆𝐫𝐨𝐰𝐭𝐡 𝐑𝐞𝐩𝐨𝐫𝐭 (𝟐𝟎𝟐𝟓-𝟐𝟎𝟑𝟓)




𝐃𝐞𝐭𝐚𝐢𝐥𝐞𝐝 𝐑𝐃- https://lnkd.in/dX7ACeFM

The North America Cell & Gene Therapy Manufacturing Services Market revenue is projected to witness exponential growth during 2020-2035. Supported by accelerating FDA approvals, investment flows, and expanding contract manufacturing capacities, the market is expected to rise from USD 1,600 Million in 2020 to over USD 8,300 Million by 2035. Key growth drivers include the advancement of personalized medicine and consistent investment in scalable manufacturing platforms to address rising demand across major therapeutic areas.

Key Drivers
Rising FDA approvals and clinical trial activities for cell and gene therapies in North America are accelerating demand for specialized manufacturing services. For instance, in June 2024, Bristol Myers Squibb expanded its cell therapy manufacturing capacity in the US to meet increased patient demand.
Strong investments and collaborations between biotechs and contract manufacturing organizations are streamlining production cycles. Recently, Thermo Fisher Scientific announced an expanded partnership with bluebird bio (July 2024) for commercial gene therapy manufacturing.

Key Trends
Adoption of automation and digital bioprocessing is enhancing the scalability and consistency of cell and gene therapy manufacturing. WuXi AppTec launched a new digital manufacturing suite in June 2024 to optimize operations and turnaround time.
Increasing outsourcing of plasmid DNA and viral vector production to contract manufacturers—Lonza reported a 40% increase in viral vector contracts in early 2024, indicating a shift toward deeper collaboration with therapy developers.

Market Insights & Segmentation
Type (Allogeneic, Autologous, Viral Vector, Non-viral Vector, Plasmid DNA, Others),
Application (Oncology, Cardiovascular Diseases, Neurological Disorders, Rare Diseases, Infectious Diseases, Others),
Distribution Channels (Direct Tenders, Third-Party Distributors, Online Platforms, Others),
Technology (Gene Editing, Cell Expansion, Viral Vector Production, Cryopreservation, Automation, Others),
Organization Size (Small, Medium, Large)

Key Market Companies
Thermo Fisher Scientific, Lonza, Catalent, WuXi AppTec, Charles River Laboratories, Oxford Biomedica, Samsung Biologics, FUJIFILM Diosynth Biotechnologies, Bluebird Bio, Cell and Gene Therapy Catapult, uniQure, Novartis, BioNTech, Bristol Myers Squibb, Editas Medicine

𝐑𝐞𝐪𝐮𝐞𝐬𝐭 𝐒𝐚𝐦𝐩𝐥𝐞 𝐏𝐚𝐠𝐞𝐬- https://lnkd.in/dem4aSgd

Comments

Post a Comment

Popular posts from this blog

𝐍𝐨𝐫𝐭𝐡 𝐀𝐦𝐞𝐫𝐢𝐜𝐚 𝐍𝐞𝐰𝐛𝐨𝐫𝐧 𝐒𝐜𝐫𝐞𝐞𝐧𝐢𝐧𝐠 𝐌𝐚𝐫𝐤𝐞𝐭 𝐒𝐢𝐳𝐞, 𝐒𝐡𝐚𝐫𝐞 & 𝐆𝐫𝐨𝐰𝐭𝐡 𝐑𝐞𝐩𝐨𝐫𝐭 (𝟐𝟎𝟐𝟓-𝟐𝟎𝟑𝟓)

Image
𝐃𝐞𝐭𝐚𝐢𝐥𝐞𝐝 𝐑𝐃- https://lnkd.in/dgM4Yq8y The North America newborn screening market is witnessing robust growth, with revenue increasing from 980 Million USD in 2020 to 1,370 Million USD in 2025, ultimately projected to reach 2,230 Million USD by 2035. This growth trajectory is attributed to increased test volumes, expanding screening panels, and greater public health investments. The upward trend underscores the region's commitment to improving neonatal health outcomes through early and comprehensive diagnostic programs, further supported by rapid technological innovation. Key Drivers Rising prevalence of congenital disorders and mandatory government regulations across the US and Canada are driving hospitals and laboratories to boost screening volumes. In 2024, PerkinElmer Inc. expanded its reagent kit offerings to meet regulatory inclusions for Cystic Fibrosis and Sickle Cell Disease screening. Key Trends Adoption of multiplex testing technologies is accelerating, allowi...
Read more

𝐔𝐒 𝐒𝐭𝐫𝐮𝐜𝐭𝐮𝐫𝐚𝐥 𝐀𝐝𝐡𝐞𝐬𝐢𝐯𝐞 𝐓𝐚𝐩𝐞𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 𝐭𝐨 𝟐𝟎𝟑𝟓 - 𝐒𝐖𝐎𝐓 𝐀𝐧𝐚𝐥𝐲𝐬𝐢𝐬 𝐚𝐧𝐝 𝐆𝐫𝐨𝐰𝐭𝐡 𝐏𝐫𝐨𝐣𝐞𝐜𝐭𝐢𝐨𝐧𝐬

Image
  𝐃𝐞𝐭𝐚𝐢𝐥𝐞𝐝 𝐑𝐃- https://bussinessinsights.com/rd/chemical-&-material/us-structural-adhesive-tapes-market   The US structural adhesive tapes market is expected to demonstrate consistent growth, with total revenue rising from $1,900 million in 2020 to a projected $4,320 million by 2035. The surge in demand is attributable to rapid industrial advancements, emphasis on sustainability, and new applications across critical sectors. 2025 is estimated at $2,450 million, showing a clear upward trend, with further acceleration anticipated due to innovation in product offerings and expansion in end-user industries. Sustained R&D investment and adaptation to regulatory changes will underpin long-term growth.   Key Drivers Growth in the automotive and aerospace sectors, where structural adhesive tapes are replacing mechanical fasteners for improved assembly efficiency, reduced weight, and enhanced safety. For example, 3M has launched new lightweight bonding...
Read more

Electronic Expansion Valves (EEV) Industry - Strategy Analysis

  The global sales of electronic expansion valves are estimated to be worth USD 886.5 million in 2025 and are anticipated to reach a value of USD 1,986.0 million by 2035. Sales are projected to rise at a CAGR of 8.4% over the forecast period between 2025 and 2035. The revenue generated by electronic expansion valves in 2024 was USD 817.8 million. The industry is anticipated to exhibit a Y-o-Y growth of 8.8% in 2025. Electronic expansion valves (EEVs) are critical components in refrigeration and HVAC systems, as they control the amount of refrigerant flowing into the evaporator but in intelligent way considering the feedback provided during the operation. Unlike traditional valves, EEVs utilize electronic control mechanisms to optimize system performance, ensuring efficient heat transfer and maintaining desired conditions. The expansion valves’ capacity to self-adjust with dynamic loads also improves energy efficiency and curbs costs, which, aligning with modern energy-saving g...
Read more